MetaCap

Amneal Pharmaceuticals Statistics

NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.65-0.645 (-3.18%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Pre-market: 19.70 +0.25%

Amneal Pharmaceuticals by the numbers

Amneal Pharmaceuticals has a market capitalization of $6.84 billion based on 348.30M shares outstanding. Its trailing P/E ratio is 40.1, and its forward P/E is 16.5. The stock trades 6.7% above its 50-day average and 30.2% above its 200-day average.

Average daily trading volume is 2.22M shares, or about $43.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AMRX valuation vs. peer median

AMRX compared with the median of 8 peer companies
MetricAMRXPeer medianDifference
Market cap$6.84B$7.04B-3%
Forward P/E16.548.2-66%
Avg. volume2.22M868.62K+155%

Peer median across 8 companies: ALKS, SYRE, IONS, BLTE, ABVX, RYTM, KNSA, PRAX.

Valuation

Price / sales (latest FY)
2.27

Price and trading

Previous close
20.30
Open
20.24
Day range
19.53 – 20.53
52-week range
9.56 – 21.18
52-week change
+89.67%
Beta
—
Volume
3.73M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
6.84B
Pe
40.10
Forward Pe
16.48
Eps
0.49
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
21.18
Week52 Low
9.56
Avg Volume
2.22M
Shares Outstanding
348.30M
Ma50
18.41
Ma200
15.09
Earnings Date
Oct 29, 2026
Pct From52w High
-7.20%
Pct From52w Low
105.54%

Related